Publications & Reports

Eliminate Tuberculosis (TB), 2022 (14)

December, 2022 (1)

  • A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis.
    Nyang'wa B-T, Berry C, Kazounis E, Motta I, Parpieva N, Tigay Z, Solodovnikova V, Liverko I, Moodliar R, Dodd M, Ngubane N, Rassool M, McHugh TD, Spigelman M, Moore DAJ, Ritmeijer K, du Cros P, Fielding K; TB-PRACTECAL Study Collaborators.
    N Engl J Med. 2022 Dec; 387(25):2331-2343

October, 2022 (1)

September, 2022 (2)

August, 2022 (1)

June, 2022 (2)

May, 2022 (1)

March, 2022 (4)

February, 2022 (2)

Year

Program

Discipline

Research Theme